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Until  now,  the  study  of dendritic  cells  (DC) x has  required  positive  selection 
techniques. Populations enriched in DC have been shown to be powerful stimulators 
first of the mixed leukocyte reaction  (MLR)  (1)  and  subsequently of a  number of 
other responses in vitro (2-11) and in situ (12,  13). 
Negative selection experiments have yet to be performed. Specific depletion pro- 
tocols would help establish ifDC are the principal ceils required for MLR stimulation 
and other accessory functions. Recently we obtained a stable hybridoma, 33D1, that 
secretes a specific anti-DC antibody (14). The 33D1 antigen appears to be found only 
on DC, at a frequency of 1-1.5 ×  104 antibody binding sites per cell. The antigen has 
yet  to  be  identified  biochemically but  most  likely,  it  is  not  an  immune  response 
associated or Ia antigen. In the presence of rabbit complement, 33D1 efficiently kills 
DC, but no other cells in spleen, node, thymus, marrow, blood, and peritoneal cavity. 
This monoclonal should provide a  way to selectively eliminate DC and to measure 
the functional consequences that ensue. 
Here  we  show  that  selective  removal  of  DC  dramatically  reduces  the  MLR 
stimulatory capacity of both unfractionated spleen and spleen adherent cells. Function 
is reconstituted with small numbers of DC purified by a technique that is independent 
of the 33D1 antibody. We propose that antigen, in combination with DC, represents 
the physiologic pathway for inducing the MLR and other immune responses. 
Materials and Methods 
Mice.  6-12-wk-old mice of both sexes were obtained from the Trudeau Institute, Saranac 
Lake,  NY (BALB/e; C57B1/6; BALB/c ×  C57B1/6  F1; DBA/2 ×  BALB/c F1; B6.H2k), and 
from the Mayo Clinic, Rochester, MN, courtesy of Dr. C. David (B 10.TL;  B 10.S (7R)). 
Antibodies.  33D1  (14) is a hybrid between the (P3×63-Ag8-U1) mouse myeloma and a rat 
spleen cell that secretes  a DC-specific  antibody (Ab). The original hybrid was cloned on soft 
agar and all seven clones evaluated were specifically cytotoxic for DC. One clone, 33D1-4, was 
injected into irradiated (600 rad), pristane primed (0.5 ml; Aldrich Chemical, Milwaukee, WI), 
D2 ×  C  F1 mice to provide ascites.  Immunoglobulin (Ig) was precipitated with two cycles of 
45% vol/vol saturated ammonium sulfate and further purified by passage over diethylamino- 
ethyl cellulose (DE-52;  Whatman, Ltd., Maidstone, England) in 0.0175  M  phosphate buffer, 
* Supported by grant AI-13013 from the National Institutes of Health and by a grant from the Cancer 
Research Institute. 
:~ Established Investigator of the American Heart Association. 
i Abbreviations used in  this paper:  Ab, antibody; C', complement; CTL, cytotoxic T lymphocyte; DC, 
dendritic cells; EA, sheep erythrocytes opsonized with anti-sheep cell serum; FCS, fetal calf serum; MHC, 
major histocompatibility complex; MLR,  mixed leukocyte reaction; Mq~, macrophages; SDS, sodium 
dodecyl sulfate. 
J. ExP. MED. © The Rockefeller University Press • 0022-1007/83/02/0613/15 $1.00  613 
Volume 157  February 1983  613-627 614  DENDRITIC CELLS  IN THE  PRIMARY MIXED  LEUKOCYTE  REACTION 
pH 6.3.33D1 Ig was stored at 1-3 mg/ml phosphate-buffered saline at 4°C. On one-dimensional 
sodium dodecyl  sulfate  (SDS)-polyacrylamide gel electrophoresis,  the  33D1  Ig had  a  single 
heavy chain band and two sharp light chain bands (see Fig.  1 and ref.  14). The heavy chain 
had the mobility of a y chain, but the subclass has not been typed. In addition to purified Ig, 
we used 33D1-4 culture supernatants grown in Dulbecco's modified medium  (Grand Island 
Biological Co., Grand Island, NY) supplemented with NCTC 109 medium (6%; M.A. Bioprod- 
ucts, Walkersville, MD), horse serum (10%; Flow Laboratories, Rockville, MD)  and fetal calf 
serum (FCS) (5%, HiClone; Sterile Systems, Logan, UT). 
F4/80 is a rat-mouse hybridoma that is macrophage (Mth) restricted (15) and does not bind 
to DC (16).  It was kindly provided by Dr. J. Austyn and Dr. S. Gordon, and used as a culture 
supernatant to stain M~ (see below). 
Two monoclonal anti-Ia reagents were used to stain and kill Ia-bearing cells. B21-2 is a rat 
anti-mouse I-A  h'd (I 7).  Purified Ig was obtained from ascites and used in cytotoxicity studies, 
while an F(ab')2 fragment was used for indirect immunofluorescence. To prepare the F(ab')2, 
an Ig fraction of B21-2 at  1.5 m g/ml 0.1M acetate buffer, pH 4.0, was digested for 4 h at 37°C 
with  2%  pepsin  (Sigma Chemical Co.,  St.  Louis, MO).  The  fragment,  which  lacked  intact 
heavy chain on one-dimensional SDS polyacrylamide gel electrophoresis, was stored at 1.1 rag/ 
ml in phosphate-buffered saline. 10-2.16 is a mouse anti-I-A  k reagent characterized by Oi et al. 
(18)  and  provided  by The  Salk  Institute,  La Jolla,  CA.  Culture supernatant was  used  to 
eliminate I-Ak-bearing cells in the presence of rabbit complement (C'). 
A mouse anti-rat Ig was produced for use in indirect immunofluorescence. Swiss mice were 
immunized with  100/Lg rat  Ig (Sigma Chemical Co.)  in complete Freund's adjuvant (Difco 
Laboratories, Detroit, MI). The injection was repeated after 1 mo. Subsequent boosts were with 
Ig in incomplete Freund's adjuvant. 4  d  after boosting, tail blood was obtained, and an Ig 
fraction was precipitated with saturated ammonium sulfate (45% vol/vol). The Ig was digested 
at 4.3 mg/ml 0.1M acetate buffer, pH 4.3, using 2% pepsin for 18 h at 37°C. F(ab')2 fragments 
were  retrieved  on  a  column of rat  Ig bound to  cyanogen bromide-activated sepharose  4B 
(Pharmacia Fine Chemicals, Piscataway, N  J). The Ig was eluted in 3 M  sodium thiocyanate 
and shown to contain no residual heavy chain on polyacrylamide gel electrophoresis run under 
reducing conditions. The F(ab')2 at  1 mg/ml was dialyzed into 0.1  M  sodium borate, pH 8.0. 
To 0.5 ml of F(ab')2, we added 50/~1 of dimethylsulfoxide with biotin hydroxysuccinimide ester 
at  1 mg/ml (a gift from Dr. S. Mojsov, The Rockefeller University) for  10 min at 4°C. The 
reaction was stopped with 50/tl  1 M ethanolamine, and the biotinylated F(ab')2 stored at 4°C. 
Cells.  Mouse spleen suspensions were obtained by teasing with fine forceps in RPMI-1640 
(Grand  Island Biological Co.).  The  suspension was  mixed with  an equal  volume of  1.66% 
ammonium chloride, layered on a 30-ml column of 10% FCS-RPMI 1640, spun at 150 g for 20 
min at room temperature, and the cell pellet was washed once more. This procedure removes 
most erythrocytes and cell debris, which are capable of fixing complement in rabbit serum. 
Adherent cells were prepared by plating 3-4 ×  106 spleen cells in 16-mm diam wells (Costar 
3524;  Rochester Scientific, Rochester,  NY)  or  150  ×  106 cells in  100-mm diam plastic petri 
dishes (3003;  Falcon Labware, Oxnard, CA).  Nonadherent cells were dislodged with pasteur 
pipettes. The firmly adherent population corresponded to  1  3% of the total cells plated and 
were  enumerated by direct  counts under an  inverted phase  contrast  microscope.  For some 
experiments adherent cells were cultured overnight (16-24 h), after which most cells could be 
dislodged into suspension with pasteur pipettes. 
DC were obtained from cultured low density spleen-adherent cells as described (2). Contam- 
inating Mth were depleted by reculturing the suspension in fresh medium on plastic petri dishes. 
Most Mt  h adhered firmly while the DC-rich suspension (80-95% pure) could be dislodged by 
gentle pipetting. 
Enriched spleen and node T  cells were  obtained by passage  over nylon-wool columns as 
described (2). Generally, 50-80 ×  107 spleen and node were passed through 1.5 gm nylon-wool 
columns with a yield of 15% of total applied cells. 
Cytotoxicity Assays.  Equal volumes of cells, Ab, and C' were mixed at  37°C for  1 h  in the 
presence of deoxyribonuclease (DNAase I, Sigma Chemical Co.) at 30/zg/ml. All reagents were 
diluted  in  cytotoxicity  medium,  which  contained  RPMI  1640  medium  with  0.3%  bovine 
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spleen adherent cells and DC were used at  6 ×  106/ml.  The antibodies were:  33D1, either 
culture  supernatant or  purified  Ig  at  100  /~g/ml;  B21-2  at  10  ~g/ml;  or  10-2.16  culture 
supernatant. The function of M~, B, and T  cells was unimpaired after exposure of spleen to 
33D1  and C'. Specifically, Mth expressed  Fc receptors and phagocytosed (14), while B and T 
cells proliferated normally to lipopolysaccharide and alloantigens, respectively (unpublished 
results).  C'  was  fresh  rabbit serum obtained from  any of three  rabbits. Rabbit blood was 
allowed to clot for 1 h at room temperature; the serum was retrieved and stored at -70°C in 
a lyophilized state. Cells were exposed to Ab and C' in plastic test tubes (2059 and 2054; Falcon 
Labware) or during adherence to 16-ram diam tissue culture wells. All cells were washed twice 
in RPMI 1640 before use. 
Immunofluorescence.  Staining was carried out on cells that were naturally adherent to glass 
coverslips  (12-mm diam, CGS; Propper Manufacturing, Long Island City, NY) or attached to 
coverslips  coated with 50/~g/ml poly-L-lysine (type VII, Sigma Chemical Co.)  in phosphate- 
buffered saline. Reagents were applied for 30-60 min at 4°C in the presence of 5% newborn 
calf serum (North American Biologicals,  Miami, FL) and 0.02% sodium azide. Coverslips were 
exposed successively to primary Ab (the monoclonal reagents 33D1, B21-2, and F4/80); 10/~g/ 
ml of biotin-labeled, affinity purified F(ab')z mouse anti-rat Ig; and rhodamine-avidin  (Vector 
Laboratories, Burlingame, CA)  at 5/~g/ml. Because  33D1 exhibits some Fc-mediated binding 
to IgG2A  receptors (19), we mixed 33D1 with a blocking IgG2A  myeloma, LPC-1, at 100/tg/ml. 
LPC-1 was not reactive with our mouse anti-rat Ig. 
After staining, the coverslips  were rosetted on ice with antibody coated sheep erythrocytes 
(EA)  prepared by opsonizing sheep erythrocytes with a  subhemagglutinating dose  of hyper- 
immune antiserum. The EA were spun onto the coverslips  and allowed to rosette for  15 rain; 
nonrosetted EA were removed by washing. The coverslips were rapidly dried with a hair dryer, 
fixed in absolute methanol for 5-10 min, and mounted in Elvanol for examination in a Zeiss 
Photomicroscope II equipped for epifluoreseence (Carl Zeiss Inc., New York). Photomicrographs 
were prepared using a constant exposure time of 60 s and Tri-X film (Eastman Kodak Co., 
Rochester, NY ). 
MLR.  Primary MLR were set up in flat-bottomed macro- (16-mm diam, Costar 3524) or 
micro- (6°ram diam, Costar 3596, Costar, Data Packaging, Cambridge, MA) wells. All stimu- 
lator populations were irradiated with  1,500 rad  (~Cs, Garnmaeell 1000; Atomic Energy of 
Canada,  Ottawa,  Canada).  Responder  cells  were  T  cells  added  at  a  dose  of  4  ×  106/ 
macrocuhure; and 3-4 ×  105/microculture. Whole spleen was never used as responders because 
DC syngeneic to the responding T  cells could promote MLR to alloantigens on Ia negative 
stimulators (see for example ref. 19). The euhure medium used was RPMI 1640 supplemented 
with 20/~g/ml gentamycin sulfate (Schering Corp., Kenilworth, N  J), 1 mM glutamine (Grand 
Island Biological Co.), 5 ×  10  -s M 2-mercaptoethanol (Eastman Kodak Co.), 5% vol/vol FCS 
(HiCione; Sterile Systems)  and  1 /~g/ml indomethacin (Sigma Chemical Co.)  to block the 
potential immunosuppressive effects of macrophage prostaglandins (5). In macrocuhures, two 
doses  of stimulators were  used  while  in microcuhures, four serial two  dilutions were  used 
[aH]thymidine (6.0  Ci/mM, 2.0 /~Ci/ml final concentration; Schwartz  Mann, Orangeburg, 
NY) was added for 14-20 h beginning  at 68 or 92 h of culture. Often the earlier time point was 
required to obtain [aH]thymidine uptakes that varied linearly with the dose of stimulator cells 
(see Results). Syngeneic MLR were small (<5-10% of the allogeneic response)  and were not 
included in the data. 
d  To monitor the development of cytotoxic T  lymphocytes (CTL), we used H-2  stimulators 
and 51Cr-labeled P815 (a DBA/2, H-2  d tumor) as targets as described (5). The CTL assay used 
0.1  ml of effector  cells obtained from MLR cultures in microtest wells  (usually at  1 3 X  106 
viable cells/ml) and 1 ×  104 51Cr-labeled targets. Percent specific SXCr-release was measured as 
experimental -  spontaneous release/total -  spontaneous release. Total cpm was measured as 
release  in 0.1 N acetic acid; spontaneous release was  10% of total. 
Results 
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(14).  Additional protocols were needed  to monitor that  33D1  only reacted with  DC 
in  heterogeneous  cell mixtures.  A  biotin-avidin immunofluorescenee  technique  was 
developed  and  first  tested  on  spleen  adherent  cells.  Adherent  DC  could  be  distin- 
guished  from  adherent  macrophages  (M~),  because  DC  lacked  Fc  receptors  and 
would not rosette EA (2, 20, 21). 33D1  only stained cells that were EA- (Fig. 1), while 
the M~ restricted monoclonal, F4/80, primarily stained EA  + cells (Table I). The B21- 
2  anti-Ia  monocional  stained  similar  numbers  of Fc-  cells  as  33D1,  and  variable 
numbers  of Fc  + ceils (Table I). In unfractionated  spleen suspensions,  33D1  failed to 
stain above the background  (no primary antibody) of 0.5-1%;  F4/80 stained 2-4% of 
spleen cells. 
The specificity of 33D1  for DC was also evident in Ab-mediated cytotoxicity. Here 
DC  were  identified by cytologic criteria  (20-23).  That  is,  DC  were  flattened,  well- 
spread cells with  mitochondria-filled processes;  M~b were primarily round  cells, and 
when spread, exhibited clear ruffles, lysosomes, and/or vesicles. When spleen adherent 
cells were prepared in the presence of 33D1  Ab and C', only viable cells adhered and 
90% of cells with the appearance of DC were eliminated. Total adherent cell numbers 
were reduced  10-40% relative to controls (No Ab or C'; Ab or C' only; Ab and heated 
C').  1-d cultures of spleen adherent  cells, which  contained  many Mq5 and  some DC 
(Fig. 2, left), were also treated with  33D1  and  C'. 95%  of the cells with  the bulbous 
Flo.  1.  Indirect immunofluorescence with biotin-avidin  (see  Materials and Methods) to visualize 
33D1 positive spleen adherent  cells. After staining, the preparations  were rosetted with EA, which 
distinguishes EA  + Mq~ from EA- DC (phase contrasts, left). Useful cytologic detail has been lost. 
because the cells were stained on ice for 3 h, dried, and fixed in methanol. 33D1 produced a speckled 
stain  (immunofluorescence, right) on many EA- cells, but did not stain  EA  ÷ cells. The reciprocal 
pattern was seen with F4/80 (see ref. 19). X 800. STEINMAN, GUTCHINOV, WITMER, AND NUSSENZWEIG  617 
TABLE  I 
33D1 Stains Adherent Spleen Dendritic Cells, but not Macrophages 
Spleen adherent cells 
Mouse strain 
Percent cells stained with 
33D1 (a-DC)  F4/80 (a-M~)  Time in  Percent 
culture  EA  + cells  EA  +  EA-  EA  +  EA- 
B21-2 (a I-A  b'd) 
EA  ÷  EA- 
h 
C X B6  l  74  2  45  78  3  55  40 
20  70  0  52  74  1  68  53 
BALB/c  l  76  1  48  70  8  23  43 
20  6l  0  71  77  1  29  65 
Spleen adherent cells  from C  ×  B6 F1 and BALB/c mice were studied after 1 or 20 h  in culture. Cells on 
coverslips were exposed successively at 4°C to: primary antibody; biotin-labeled, affinity-purified, F(ab')~ 
mouse anti-rat Ig; and rhodamine-avidin.  EA were then spun onto the monolayers to identify Fc-bearing 
cells. Finally, the coverslips were dried rapidly and fixed in absolute methanol. At least 100 EA  + and EA- 
cells were evaluated for expression of three different surface antigens, as illustrated in Fig. 1. 
pseudopods typical of cultured  DC  were killed (Fig. 2,  compare  middle and  right). 
No killing was detectable in fresh or cultured whole spleen. Together with previous 
data  (14),  we  conclude  that  33D1  reacts  with  the  trace  DC  component  of mouse 
spleen. Specificity can be monitored by cytotoxicity and immunofluorescence assays 
on adherent spleen cells. 
Effects of the 33D1 Ab on the Function of Enriched Spleen DC.  When enriched popula- 
tions of DC were exposed for  1 h  to both 33D1  Ab and C', the cells were killed and 
MLR  stimulatory capacity was ablated  (Table IIA). Killing of DC  and elimination 
of function did not occur with Ab only, C' only, or Ab plus heated C'. 33D1  Ab and 
C' also eliminated function when lysis was performed in the presence of large numbers 
(30-fold excess) of "filler" or nonstimulatory lymphocytes (Table IIA). 
Purified  33D1  (30  /~g/ml;  saturation  is  at  10-15  /~g/ml  [14])  was  next  added 
continuously  to  cocultures  of T  cells  responding  to  small  numbers  of  irradiated, 
enriched  DC.  No  inhibition  of  the  MLR  was  noted  (Table  IIB).  Purified  DC 
populations lacked M~, and it was conceivable that  33D1  could inhibit function by 
opsonizing DC  in  the  presence  of Fc receptor-bearing cells. We  therefore  included 
experiments  in  which  adherent  peritoneal cells  (primarily M~b) were  added  to  the 
DC-T cell co-cultures. The M4~ were not themselves active as MLR  stimulators and 
had little effect on DC function, even in the continuous presence of 33D1  (Table IIB). 
We  conclude  that  33D1  does  not  itself interfere  with  MLR  stimulation,  but  that 
killing DC with Ab and (3' abolishes function. 
Effects of Selective Dendritic Cell Depletion on the MLR Stimulating Capacity of Unfractionated 
Spleen.  Treatment  of spleen cells with  33D1  Ab and C' reduced MLR  stimulator,/ 
capacity 75-90%  (Table III). Stimulation by both  fresh and cultured  (24  h)  spleen 
cells was reduced similarly. In general, the inhibition was similar to that produced by 
anti-Ia Ab and C'. However, 33D1 killed <1% of spleen cells, whereas anti-Ia routinely 
killed 60-70%.  In  most  experiments,  33D1  Ab  alone  did  not  diminish  stimulatory 
capacity;  specific  anti-Ia  Ab  alone  usually  reduced  stimulation  by  50%  or  more, 
particularly at high stimulator/responder ratios (Table III). 
Treatment with 33D1  and C' also reduced stimulation of the CTL response typical 
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Fro.  2.  (Left)  Identification of the DC  and  M~b components of cultured  spleen adherent  cells. 
Adherent spleen cells were cultured 24 h and dislodged from the tissue culture dish. 2-3 ×  104 cells 
were attached to poly-L-lysine-coated  covcrslips  for 30 min at 4°C, and then EA were spun onto the 
coverslips  for 20 rain at 4°C to mark Fc  + cells. Nonrosetted EA were removed by washing, and the 
coverslips  were  fixed in  1.25% glutaraldehyde. This technique provides concentrated viable popu- 
lations in which most of the cells strongly rosette EA.  The latter are M4~ defined by phagocytic 
activity and expression of the F4/80 Mq~ restricted antigen (e.g., Table I). The EA- cells include 
spiny DC (arrows)  and some round cells. ×  800.  (Middle) Cultured spleen adherent cells that were 
exposed to rabbit C' for  1 h at 37°C, before attachment to poly-L-lysine  coated coverslips at 4°C. 
Most of the cells were round, but DC covered with cell processes (arrows) could be identified. X 800. 
(Right) Same as middle, but the adherent cells were treated with both 33D1  anti-DC Ab and C'. 
Only viable cells attached to the coverslips.  The irregularly shaped DC were eliminated. ×  800. 
stimulator dose) restored function, whether  DC  had  been removed  with 33D 1 or anti- 
Ia Ab and  C'  (experiment  B, Table  IV).  We conclude  that  small numbers  of DC  are 
essential for primary  MLR  stimulation  by mouse spleen. 
Effect  of Selective  Dendritic  Cell  Depletion  on  MLR  Stimulation  by  Spleen  Adherent  and 
Nonadherent  Cells.  To compare  MLR  stimulation  by spleen  DC  and  M~b directly,  we 
studied  the effects of 33D1  and  C' on  isolated spleen  adherent  cells.  The  latter were 
prepared  under  conditions  in  which  most  lymphocytes  were  removed  by  pipetting 
over  the  tissue  culture  surface.  Adherent  cells  represented  1-3%  of  the  cultured 
inoculum. 
Fresh  spleen  suspensions were  first  adhered  to  plastic  in  the  presence of 33D1  Ab 
and  C',  or suitable controls  (Table  VA).  Stimulation  by adherent  ceils was  reduced 
>90%  if  DC  had  been  eliminated.  Nonadherent  spleen  was  much  less  active  as 
stimulators  on  a  per  cell  basis,  but  stimulation  was  also  sensitive  to  33D1  and  C'. 
Small  numbers  of  enriched  DC  (2  ×  104/macroculture)  reversed  the  inhibition 
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TAaL~  II 
Effect of Monoclonal Anti-DC Ab on MLR stimulat,'on by Enriched Populations of DC 
(A) Initial Exposure to 33D1 Ab with or without C' 
619 
Treatment  Stimulators  (A/C') 
Proliferative response in 3 ×  105 B6 T cells (cpm [3H]- 
thymidine uptake) induced by D Cells at a dose of: 
2 ×  10  4  1 ×  10  4  5 X  10  ~  2.5 ×  10  a 
DC-C ×  BnF1  None/heat  58,887  46,237  26,930  12,730 
DC-C ×  BsF1  None/fresh  56,813  38,033  20,960  11,172 
DC-C ×  BnF1  33D1/heat  46,532  32,826  17,691  8,655 
DC-C X BnF1  33D1/fresh  3,305  1,727  1,343  Not done 
DC +  B6 T cells  None/fresh  43,209  24,280  11,834  6,229 
DC +  B6 T cells  33D1/fresh  2,500  1,283  1,001  1,159 
Bs T cells only  None/fresh  548  957  1,210  1,265 
Bs T cells only  33D I/fresh  692  901  1,012  1,235 
DC were prepared from BALB/c ×  C:57B1/6 FI low density spleen adherent cells. 40/.tl of cells at 5 ×  106/ 
ml were treated with equal volumes of medium or 33D1  antibody (100 #g/ml) and rabbit serum (heated 
56°C for 30 min or reconstituted  fresh from lyophilized stocks). After 1 h, the cells were washed, irradiated, 
and used to stimulate allogeneic C57BL/6, nylon wool-nonadherent spleen and lymph node cells (T cells). 
In the lower half of the experiment, 6 ×  I06 C57BL/6 T cells were treated in conjunction w~th DC, to test 
whether filler cells interfered with 33Dl-mediated killing. The T ceils were themselves insensitive to 33Dl, 
and were used in the cultures at doses of 4, 2, 1, and 0.5 ×  10b/well. Proliferative responses were monitored 
at 67-72 h; the background without stimulators was 1,345 cpm and was not subtracted. 
(B) Continuous Exposure to 331)1 Ab 
Supplement 
2X  104C X 
33D1 Ab  B6 Ft mac- 
(30 #g/ml)  rophages 
Proliferative response in 4 ×  l0  b BALB/c T cells (cpm [aH]thymidine 
uptake) induced by DC at a dose of: 
8X  10  3  4X  10  a  2×  10  a  1 X  10  a 
-  -  58,420  22,840  8,122  4,692 
+  -  59,975  26,872  8,389  3,996 
-  +  60,929  32,443  18,211  10,753 
+  +  40,161  23,488  13,018  8,840 
Primary MLR were generated by adding irradiated DC to allogeneic T  cells. Some of the cultures were 
supplemented with purified 33D 1 antibody at a final concentration of 30 #g/ml, and/or with irradiated, 
1-d cultures of peritoneal macrophages (2 ×  104 adherent peritoneal cells, which are >95% macrophages 
and have few detectable DC). Thymidine pulse was at 76-92 h. Maximum response of syngeneic T cells 
was 4,000-5,000 cpm for all supplements. All "no stimulator" backgrounds were 900-1,200 cpm and were 
not subtracted. Responses to allogeneic peritoneal cells alone were 4,050 and 4,176 cpm +  33D 1 antibody, 
respectively. 
This  type  of  experiment  was  performed  seven  consecutive  times  using  strain 
combinations  that  differed  in  the entire  major  histocompatibility  complex  (MHC) 
(e.g.,  B6.H2k  stimulating  D2  ×  C  Fa  responders)  or  in  specific  MHC  subregions 
[B 10.S(7R)  =  K~I~D  d stimulating  B 10.TL =  K~IkD  a responders and  Br.Hzk  =  KklkD k 
stimulating  B10.TL  --  K~IkD  d  responders].  In  all  cases,  a  similar  phenomenon  was 
observed  (Table  VB).  The  bulk  of the  stimulating  capacity  (62  ±  8%)  was  in  the 
adherent  population  and  was  ablated  when  DC  were  removed.  A  small  fraction  of 
MLR-stimulating  activity was induced by nonadherent  cells; stimulation  was reduced 
by 33D1  and C', but  not to the same extent as in the adherent  fraction. A  number  of 
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TABLE  III 
Treatment With Monoclonal Anti-DC Antibody (33D1) and C' Inhibits  The MLR Stimulating Capacity 
of Fresh and Cultured Mouse Spleen Cells 
Treatment of stimulators  Proliferative response (cpm [3HlThymidine uptake)  induced by 
(Ab/C')  stimulators at a dose of 
4X  l0  s  2×  105  1 X 105  5 ×  104 
Experiment A 
None/heat  29,992  16,694  6,436  3,129 
None/fresh  24,712  13,257  9,422  6,321 
a-DC/heat  22,825  17,575  9,941  7,494 
a-DC/fresh  6,998  2,076  1,301  950 
~-LAk/heat  13,557  11,762  7,932  3,590 
a-LAk/fresh  2,750  1,565  1,075  860 
2x  10  s  l ×  105  5x  104  2.5X  104 
Experiment B 
None/heat  59,497  46,839  21,981  10,144 
None/fresh  60,726  35,868  19,664  8,283 
a-DC/heat  78,753  46,619  25,117  10,409 
a-DC/fresh  17,988  4,370  2,165  1,749 
a-I-Ak/heat  31,876  23,938  15,384  6,821 
a-I-Ak/fresh  13,726  9,546  5,020  3,277 
Experiment C 
None/heat  27,680  15,916  7,227  3,475 
None/fresh  30,063  22,584  10,616  4,231 
a-DC/heat  29,241  16,913  6,275  4,070 
a-DC/fresh  6,191  1,299  990  881 
c~-l-Ak/heat  15,0 l 2  7,164  4,3 l 5  2,503 
a-I-Ak/fresh  10,279  7,163  3,678  2,469 
Fresh or cultured (24 h) spleen cells were exposed  to Ab and C' (heat  inactivated for 30 rain at 56°C, or 
freshly reconstituted from lyophilized stocks) for 1 h at 37°C in polypropylene tubes. The cells were washed 
twice and were irradiated (1,500 rad).  Serial two dilutions of cells were pipetted into microtest wells and 
cultured with nylon wool nonadherent, spleen  and lymph node cells (T cells). The "no stimulator cell" 
k  background cpm were not subtracted from the data.  (A) Fresh B6.H2k spleen  (H-2) stimulating D2 ×  C 
d  d  3  Fl (H-2  ×  H-2 ) T  cells. [ H]thymidine pulse at 72-90  h. No stimulator cultures  incorporated 998 cpm. 
(B) Cultured B6.H2k spleen stimulating D2 × C F1 T cells. [3H]thymidine  pulse at 48-64 h. No stimulator 
cultures  incorporated 1,775 cpm. (C) Cultured B6.H2k spleen stimulating C × B6 F1 T cells (H-2 a X H-2b). 
[3H]thymidine  pulse at 48-64 h. No stimulator cultures  incorporated 602 cpm. 
without success. These approaches  (not shown) included: testing different preparations 
of 33D 1 purified Ab and culture supernatants;  use of 20 different nontoxic rabbit sera 
as  C'  sources;  varying  the  dose  of cells,  Ab,  and  C'  during  the  lytic  steps;  double 
treatments  with 33D1  and  C'; and  elimination of DC in the responding  T  cells with 
33D 1 or anti-Ia Ab and  C'. 
Stimulation  by  cultured  spleen  adherent  cells was  also  studied.  Because  cultured 
cells  could  be  dislodged  from  the  plastic  surface  into  a  viable  suspension,  more 
concentrated  populations  than  fresh adherent  cells could be tested.  Selective removal 
of  DC  with  33D1  and  C'  again  eliminated  the  stimulating  activity  of  cultured 
adherent  cells,  even  though  Ia  +  M4~  outnumbered  DC  several-fold  (Table  VI). 
Therefore,  DC  and  not  Ia  +  M~  are  responsible  for  MLR  stimulation  in  spleen 
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TABLE IV 
Dendritic  Cells are Required to Stimulate Both Proliferative and Cytotoxic Responses in the Primary MLR 
T cell response to graded doses of allogeneic stimulators: 
Stimulators (cell/treatment)  cpm [~H]thymidine uptake (percent 5tCr Release) 
4X  10  5  2x  10  5  1 X  10  5  0.5X  10  5 
Experiment A 
Spleen, no Ab/(2'  43,041 (83)  26,743  (64)  14,515  (37)  7,604 (11) 
Spleen, a D(2/C'  10,911 (14)  6,094 (5)  1,937 (0)  1,249 (0) 
Spleen, a I-Ak/C  '  35,289 (77)  22,144  (39)  10,881 (18)  5,325 (9) 
Spleen, a I-Ab'd/(2  '  1,980 (0)  1,547 (0)  1,192 (0)  1,109 (0) 
2.4 ×  105  1.2 ×  105  0.6 ×  105  0.3 ×  105 
Experiment B 
Spleen, no Ab/C'  29,479 (45)  14,822 (25)  9,101 (19)  5,840 (7) 
Spleen, a D(2/(2'  5,499 (4)  3,326 (2)  1,602 (0)  1,249 (0) 
Spleen, a I-Ab'd/c  '  4,565 (5)  3,712 (4)  1,761 (0)  Not done 
D(2 only  33,759 (26)  10,514 (20)  4,035 (7)  2,536 (3) 
DC + spleen, a D(2/C'  37,138 (51)  20,605  (45)  5,925 (27)  2,200 (3) 
D(2 + spleen, a I-Ab'd/c'  23,814 (55)  16,400 (40)  7,018 (22)  3,033 (9) 
Spleen cells were treated with monoclonal Ab and fresh rabbit C' for  1 h at 37°(2, washed,  irradiated 
(1,500 rad), and added in varying doses to 3 ×  105 nylon wool-nonadherent spleen cells. One plate was 
used to monitor the proliferative  response (cpm [aH]thymidine uptake at 70-90 h). A replicate  plate was 
used to quantitate lytic activity (percent 5~Cr release from P815 targets  assayed at  116-120 h at effector/ 
target  ratios of 10-30:1; spontaneous 51Cr release of 10%). In experiment A, BALB/(2 (H-2  d) stimulated 
B6.H2k (H-2  k)  responders.  [3H]thymidine  uptake in the no-stimulator background was  1,438 cpm  (not 
subtracted).  In experiment B, C  ×  B6F~ (H-2  d ×  H-2  b)  stimulated C57B1/6  (H-2  b)  responders.  [SH]- 
thymidine uptake in the no-stimulator background was  1,493 cpm (not subtracted). DC were obtained 
from low density spleen adherent cells as described  (2). DC were used as stimulators at a top dose of 1.2 
×  l0  s either alone,  or in conjunction with spleen  cells treated  with aD(2  or aI-A  b'd Ab and C'.  DC 
accounted for 0.5% of stimulators at all doses. 
Discussion 
DC as Unique Stimulators of the MLR.  MLR-stimulating  capacity is reduced by 75- 
90% when the number  of DC  in whole spleen or spleen adherent cells is diminished 
with specific Ab  (clone 33D1)  and C'.  Function can be restored by adding back DC 
in numbers comparable to those found in the spleen (0.5% of total cells) and prepared 
by a  technique that  is independent of 33D1  Ab. These observations provide the best 
evidence  for  the  unique  functional  properties  of  DC.  Previous  experiments  with 
positive selection have led to a  similar conclusion. Specifically, populations enriched 
in DC are potent stimulators, whereas lymphocytes and macrophages are not (1, 2, 9, 
11,  17). Current positive selection procedures have some drawbacks, however.  No cell 
type  is obtained  in >25-50%  yield; considerable manipulation, e.g.,  adherence  and 
tissue culture,  is  required  for  purification;  and  it  is  difficult  to  rigorously correlate 
functional activity with numbers of DC, since it is difficult to count DC  in any cell 
population  that  has  not  undergone  some  sort  of enrichment  procedure.  Negative 
selection provides a minimum estimate of the amount of activity that can be attributed 
to  DC,  whether  the  cell  acts  by  direct  stimulation  of  responding  T  cells  or  by 
enhancing stimulation to antigens on other cells. Furthermore, negative selection can 
be performed on fresh spleen suspensions. 
Cell-specific reagents have seen little use in the identification of MLR  stimulators. 
It has been shown that  B  and T  cell elimination (with anti-Ig or anti-Thy-1 plus C') 
does not alter stimulatory capacity  (1).  Specific anti-mouse Mq~ reagents have yet to 622  DENDRITIC  CELLS  IN  THE  PRIMARY  MIXED  LEUKOCYTE  REACTION 
TABLE V 
The Effect of Selective DC Depletion on the MLR Stimulating Capacity of Spleen Adherent  and 
Nonadherent Cells 
Part  A 
T cell proliferative re- 
Stimulator cells*  Treatment (Ab/C'):~  sponse (cpm [aH]Thy- 
midine uptake)§ 
None  None  1,205; 695 
1.2 ×  105 Adherent spleen  None/heat  70,779; 68,035 
1.2 ×  105 Adherent spleen  None/fresh  60,647; 55,997 
0.3 ×  10  ~ Adherent spleen  None/fresh  19,930; 20,500 
1.2 ×  105Adherent spleen  33Dl/heat  65,307; 74,180 
0.8 ×  105 Adherent spleen  33Dl/fresh  2,197; 4,336 
0.2 ×  105 Adherent spleen  33Dl/fresh  965; 724 
0.8 ×  10  s Adherent spleen  33Dl/fresh  76,654; 55,467 
+ 0.2 x  105 DCII  None 
2.4 ×  l0  s Nonadherent spleen  None/heat  35,875; 32,627 
2.4 ×  106 Nonadherent spleen  None/fresh  32,943; 33,468 
0.6 x  I06 Nonadherent spleen  None/fresh  10,900; 8,517 
2.4 x  10  n Nonadherent spleen  33D1/heat  31,747; 35,179 
2.4 ×  I06 Nonadherent spleen  33D1/fresh  5,875; 7,021 
0.6 ×  106 Nonadherent spleen  33D1/fresh  1,946; 1,363 
2.4 x  106 Nonadherent spleen  33Dl/fresh  62,108; 48,870 
+  0.2 X 105 DC  None 
0.2 ×  105 DC only  None  32,461; 41,423 
* 3.3  ×  10  n B6.H2k spleen  cells were irradiated  (1,500 rad),  and  exposed to  antibody and  C'  during 
adherence to  16-ram diam  plastic tissue  culture  wells  in  duplicate.  After 60-80  rain  at  37°C,  the 
nonadherent cells were removed by gently pipetting over the surface of the well. The nonadherent cells, 
which represented >90% of the recovered cells, were washed and added to separate wells. 
:~ Cells were exposed to medium (no antibody) or an Ig fraction  of 33D1, anti-DC antibody at  !00/zg/ml. 
Complement was rabbit serum,  final dilution of 1:16, that had been heat inactivated (56°C, 30 min) or 
reconstituted "fresh" from lyophilized  stocks. 
§ 4 ×  106 nylon wool-nonadherent spleen and lymph node cells from D2 ×  C FI mice (T cells) were used 
as responders.  Total culture volume was 2.0 ml. At 96 h, triplicate aliquots of 0.2 ml were transferred 
from the 16-ram wells to microtest  plates (6-mm diam wells) and exposed to [aH]thymidine (2/tCi/ml 
final concentration) for 16 h. 
[[ DC were obtained from low density, spleen adherent monolayers;  the latter were cultured overnight and 
depleted of macrophages by readherence to plastic as described (2). 
be used because current monoclonal Ab are not cytotoxic. However, van  Voorhis et 
al,  (manuscript  in  preparation)  have  selectively eliminated  human  Ia  +  monocytes 
with  a  specific cytotoxic  monoclonal  Ab,  and  have  found  no  reduction  in  MLR 
stimulation  by  blood  leukocytes.  Most  investigators  have  used  anti-Ia  and  C"  to 
eliminate MLR  stimulators. Ia is not a  cell-specific marker and can be expressed on 
nonleukocytes as well as all classes of mononuclear leukocyte. Treatment  with anti-Ia 
plus C' would remove the Ia-rich  DC.  We think it  is by virtue of its DC  specificity 
that  33D1  represents the  first  cell  specific reagent  to  have  such  marked  effects on 
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Part  B 
Primary MLR strain combination 
Treatment of stimu- 
lator cells 
Proliferative response 
(cpm [3H]thymidine  uptake) 
induced by 
Irradiated stimula-  Nonadherent  T cell responder  Adherent cells  tor  cells 
B6.H2k  D2 × CFI  No  57,372  32,256 
33D 1  2,316  5,498 
B6.H2k  D2 × CF1  No Ab  37,264  10,685 
33D 1  5,545  5,565 
B6.H2k  D2XC FI  No Ab  31,040  20,057 
33D 1  2,400  10,681 
B  10.S(7R)  B  10.TL  No Ab  30,570  24,767 
33D 1  1,628  7,657 
B6.H2k  B  10.TL  No Ab  41,738  23,462 
33D1  580  10,213 
B6.H2k  D2×C Fl  No Ab  40,907  32,046 
33D1  6,327  21,730 
B6.H2k  C×B6 F1  No Ab  24,052  16,930 
33D l  1,970  3,807 
As described above (A), adherent and nonadherent spleen cells were prepared during treatment with fresh 
C' ±  33D1 anti-DC antibody. Three  different rabbits were used as C' donors. The data in the  first 
experiment are taken from Table VA. The second experiment was performed in the same detail as above 
with similar results (heated complement controls; low and high doses of stimulators; reconstitution with 
low doses of enriched dendritic cells). In all experiments, adherent cells and nonadherent cells numbered 
~1  ×  105/culture and 2.5  ×  106/culture, respectively. Pulsing with [aH]thymidine was performed by 
transferring aliquots to microtest wells before labeling (as Table VA); alternatively, [aH]thymidine was 
added to the  16-ram wells followed by transfer to microtest wells at the time of harvest. [SH]thymidine 
incorporated by T cells alone, which ranged from 800 to 2,000 cpm, has been subtracted from all entries. 
If DC  are  unique MLR  stimulators, why  does  treatment with  33D1  and C' not 
remove 100% of stimulating capacity in spleen? One possibility is that 33D1  does not 
kill all DC.  The Ab efficiently eliminates DC enriched by adherence (Tables II, V, 
VI).  However,  there  may  be  DC  that  are  more  difficult  to  kill,  particularly  in 
nonadherent spleen cells. Nonadherent DC could express less antigen, or the antigen 
may be occupied and inaccessible to Ab. Such differences in antigen expression may 
in turn reflect differences in DC maturation and/or activation. A  second possibility 
relates to the contribution of soluble mediators (interleukins). For example, antigen 
on any cell plus soluble factors may effectively trigger development of CTL (e.g., 24, 
25).  Interleukins might  be  generated by very small numbers of DC  resisting 33D1 
plus C', or by spleen cells that were triggered by antigen in the animal before killing. 
Relevance  of the Prima~y MLR Data to Tissue Transplantation.  Allografts could contain 
small numbers of allogeneic DC that trigger first set rejection. Thus allograft rejection 
would be comparable to the primary MLR, in which trace numbers of DC induce the 
response. This hypothesis gains support from several recent studies in rats. Hart and 
Fabre  (26)  identified cells  in  tissue sections of most  nonlymphoid organs  that  are 
similar to  DC.  Klinkert et  al.  (11)  have isolated DC  from liver and skin, and have 
shown that their accessory function is comparable to lymphoid DC. Cells similar to 
DC  have been identified in rat  afferent lymph (7,  8), so that  DC could move from 
allograft to host lymphoid organ once lymphatic connections are established. Lechler 
and  Batchelor  (13)  showed  that  small  numbers of DC,  obtained from  rat  lymph, 624  DENDRITIC CELLS  IN  THE  PRIMARY  MIXED  LEUKOCYTE  REACTION 
TABLE  VI 
Selective Depletion of DC Ablates the MLR Stimulating Capacity of Cultured Spleen Adherent  Cells 
Treatment of stimulators 
(Ab/C') 
Proliferative response (cpm [3H]thymidine  uptake)  induced by 
stimulators at a dose of 
3.2 X 104  1.6 X 104  0.8 X  104  0.4 ×  104 
Experiment A: C ×  B6 F1 stimulators,  B6 responders 
No Ab/No C'  38,582  21,420  6,511  2,582 
No Ab/C'  23,940  10,404  3,518  7 I0 
aDC/No C'  26,210  16,405  8,293  2,436 
aDC/C'  180  141  89  55 
aI-Ab'd/No C'  18,622  11,393  2,265  583 
aI-Ab'a/C'  NT*  NT  120  57 
aI-Ak/No C'  31,687  16,311  7,202  2,091 
al-Ak/C  '  31,396  18,035  7,655  1,622 
Experiment B: B6.H2k stimulators,  B6 responders 
No Ab/No C'  27,525  25,698  13,896  4,254 
No Ab/C'  28,060  16,282  5,986  1,433 
aDC/No C'  29,541  16,501  8,206  3,084 
aDC/C'  72  80  162  166 
aI-Ab'd/No C'  36,1 l 7  25,923  13,263  6,701 
aI-AM/C '  22,292  I 1,860  3,056  283 
aI-Ak/No C'  16,988  16,433  9,399  3,064 
aI-Ak/C  '  NT  169  193  87 
Spleen adherent cells were prepared from Balb/c ×  C57B1/6 F1 (I-Ab'd; experiment A) or from B6 Hzk 
(I-A  k, experiment B) mice. Aliquots of cells in suspension  were treated with Ab (none, 33D1 a-DC, B21- 
2 a-I-A  TM, or 10-216 a-I-A  k) with or without C'. The cells were washed,  irradiated, and added in graded 
doses to 4 ×  105 nylon wool nonadherent spleen cells. [3H]thymidine  uptake was measured at 72-90  h. 
Background  (no stimulators)  was  105 and  135 cpm and was not subtracted.  In both experiments, 33D1 
killed  10% of the adherent cells. Specific ~-I-A killed 75% of the adherent cells in experiment A, and 50% 
in experiment B. Since cultured spleen adherent cells were not detectably killed with alg or athy-l, la  + 
macrophages  had to outnumber Ia  + DC several-fold in both experiments. 
* Not tested. 
triggered  rejection  of rat  kidney  allografts.  Therefore,  depletion  of allogeneic  DC 
might  well explain  the  survival  of allografts  that  have  been  cultured  for  prolonged 
periods  (27,  28)  or that  have been treated with anti-Ia and  C'  (29). 
A  second possibility is that  host DC, especially in lymphoid organs, act as accessory 
cells for responses  to alloantigens on other cells. In support  of this possibility, there is 
in vitro evidence that DC syngeneic to the responder,  as well as third-party  allogeneic 
DC, markedly enhance CTL  responses to alloantigens on thymocytes and  Ia-negative 
spleen cells (19).  Nussenzweig et al.  (5)  have also demonstrated  that  DC enhance the 
CTL  response  to hapten-modified  but  otherwise nonimmunogenic  T  cells. 
A  final  possibility  is  that  certain  grafts  bypass  the  need  for  DC  by  themselves 
producing  soluble  mediators,  termed  costimulators  by  Lafferty  and  associates  (30). 
Costimulators  in turn  may resemble those produced  during  DC-T  cell interaction. 
The MLR  as a  Model for Accessory Cell Function.  The  term  "accessory cell" refers  to 
a  nonlymphocytic  element  required,  in  addition  to  antigen  or  other  stimulus,  to 
induce  a  lymphocyte  response.  Our  interest  in  accessory cells began  with  a  study  of 
adherent  spleen  cells  (22).  At  the  time,  adherent  spleen  was  the  principal  source  of 
accessory cells in mice, and function was evaluated by stimulation of antibody forming 
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distinct class of DC and were not simply a source of Mff as is often assumed (reviewed 
in  23).  Further  analysis required  that  DC and M(b be studied  separately, either by 
positive or negative selection techniques.  Both have now been accomplished for the 
primary MLR (1,  2, 9,  11,  17, 23). The MLR effectively illustrates the need for DC 
as  accessory cells  in  the  induction  of immune  responses.  The  antigens  are  almost 
certainly the known class I  (H-2) and II (Ia) alloantigens of the major histocompati- 
bility complex. Mff and lymphocytes express antigen, yet they need not stimulate the 
MLR.  Antigens,  to  be  immunogens,  require  accessory cells.  Further  studies  must 
explain how DC, which may be considered to be "nature's adjuvant," function in the 
MLR and other responses. 
Summary 
Clone 33D1  is a  mouse-rat hybridoma that  secretes a  specific anti-dendritic  cell 
(DC)  monoclonal  antibody  (14).  Because the  antibody  kills  DC  in  the presence of 
rabbit complement, it can be used to study the functional consequences of selective 
DC depletion.  Previous data on the cell specificity of 33D1  were first extended.  By 
cytotoxicity  (rabbit  complement)  and  indirect  immunofluorescence  (biotin-avidin 
technique),  33D1  reacted with DC but not with macrophages nor other splenocytes. 
In contrast, the monoclonal antibody, F4/80  (15), reacted with macrophages but not 
DC. 
The functional assay evaluated in this paper was stimulation of the primary mixed 
leukocyte  reaction  (MLR).  33D1  antibody  itself  did  not  inhibit  stimulation  by 
enriched  populations  of DC.  In  the  presence of complement,  33D1  killed  DC and 
ablated stimulatory function. 
The effect of 33D1  and  complement on  MLR  stimulation  by heterogenous  cell 
mixtures was then evaluated. Removal of DC from unfractionated spleen suspensions 
reduced  stimulatory  capacity  75-90%,  comparable  to  that  produced  with  specific 
anti-Ia antibody and  complement.  Stimulation  of both  proliferative and  cytotoxic 
responses was reduced.  DC depletion  had similar effects on MLR generated across 
full  strain  differences,  or  across  selected  subregions  (H2I,  H-2K/D)  of the  major 
histocompatibility complex. 
To further compare the functional properties of spleen DC and macrophages, MLR 
stimulation by adherent and nonadherent  fractions of spleen were tested separately. 
62  ±  8%  of the  total  stimulatory  capacity  of spleen  was  in  the  plastic  adherent 
population. Activity was ablated >90% after elimination of DC. MLR stimulation by 
24-h cultures of spleen adherent cells, which contained a three- to sixfold excess of Ia  + 
macrophages, was also ablated when DC were removed. Stimulation by nonadherent 
spleen was more resistant, but was reduced 50-75% by 33D1  and complement. 
The function of spleen cells treated with 33D1 or anti-Ia antibody and complement 
was restored with a small inoculum of purified DC. The latter corresponded to 0.5% 
of total stimulator cells and were enriched  by previously described  techniques  that 
did not require the 33D1 antibody. 
We conclude that the DC, a trace component of mouse spleen, is the principal cell 
type  required  for  stimulation  of the  primary  MLR.  Because  other  cells  are  not 
immunogenic, but do express Ia and H-2 alloantigens, DC likely represent the critical 
accessory cell required for the induction of lymphocyte responses. 626  DENDRITIC  CELLS IN THE  PRIMARY MIXED  LEUKOCYTE  REACTION 
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